PB

Paul Bresge

Chief Executive Officer & Co-Founder

Ray Therapeutics

Ray Therapeutics Pipeline

DrugIndicationPhase
RTx-015Retinitis PigmentosaPhase 1
RTx-021Stargardt’s DiseaseDiscovery